Monica Farley, MD
VA Medical Center, Atlanta
Georgia Emerging Infectious Program
Division of Infectious Diseases, Emory University School of Medicine
Phone: 404-321-6111 (ext. 2094)
My major laboratory research interests concern mucosal pathogenesis of Haemophilus influenzae. Experiments have focused on the mechanisms of attachment, colonization and invasion of human nasopharyngeal mucosa by H. influenzae. Previous research involved a detailed examination of the role of pili (a specific bacterial surface component) in mucosal attachment and pathogenesis. Current laboratory research is focused on molecular epidemiology of invasive bacterial pathogens including H. influenzae, Streptococcus pneumoniae, and MRSA.
My clinical research interest is in population-based surveillance and epidemiology of bacterial meningitis pathogens including (H. influenzae, N. meningitidis, groups A and B Streptococcus and S. pneumoniae), bacterial foodborne diseases and influenza viral infections. I am the Principal Investigator for the CDC-funded Georgia Emerging Infections Program.
She serves as the Principal Investigator for the Georgia Emerging Infections Program (EIP), a CDC-funded surveillance network of epidemiologic and clinical research groups focused on invasive bacterial pathogens, influenza and foodborne diseases. The research program, in place in Atlanta since 1988 and currently covering the entire Metropolitan Atlanta area, has been highly productive, providing population-based assessment of the epidemiology and risk factors for a number of important bacterial infections, including pneumococcal disease, Clostridium difficile infections and community-associated MRSA disease. Other EIP projects include post-licensure vaccine effectiveness studies for influenza, Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines. She has also studied molecular mechanisms of H. influenzae pathogenesis in her laboratory.
- View publications on PubMed